BGM Group Ltd. Class A
As of Oct 22, 2026, BGM Group is in Stage 1, the basing phase, now in its first week (since Oct 21, 2026). It closed at $8.20, 97.2% below its 52-week high and below its 200-day average, which is falling.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is BGM early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
BGM among Drug Manufacturers - Specialty & Generic78th of 84 by relative strength
All 84 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CPIX | Stage 2 · wk 23 | 98 | +6.8% |
| 2 | ETON | Stage 2 · wk 30 | 97 | −10.1% |
| 3 | ANIK | Stage 2 · wk 15 | 96 | +3.5% |
| 4 | IRWD | Stage 3 · wk 3 | 96 | −16.4% |
| 5 | TEVA | Stage 2 · wk 9 | 95 | +3.1% |
| 6 | AMRX | Stage 2 · wk 19 | 95 | +5.9% |
| 7 | KNSA | Stage 2 · wk 73 | 95 | +6.2% |
| 8 | AMLX | Stage 2 · wk 15 | 93 | −6.6% |
| …78 | BGM | Stage 1 · wk 1 | 4 | +7.2% |
BGM Group: quick answers
What stage is BGM Group in?
As of Oct 22, 2026, BGM Group (BGM) is in Stage 1, the basing phase. It entered Stage 1 on Oct 21, 2026 and is in its first week there. What the four stages mean
Is BGM Group in an uptrend?
Not yet. BGM Group is in Stage 1, a base that can come before an uptrend. It trades 63.3% below its 200-day average, which is falling.
How far is BGM Group from its 52-week high?
BGM Group closed at $8.20 on Oct 22, 2026, 97.2% below its 52-week high of $296.55. Its 52-week low is $7.20.
How has BGM Group performed over the past year?
As of Oct 22, 2026, BGM Group is down 97.1% over the past year and down 92.4% so far in 2026.
Which sector and industry is BGM Group in?
BGM Group is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.
About this companyHealth Care· Drug Manufacturers - Specialty & Generic
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a antitussive and expectorant medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce compound licorice oral solutions. In addition, it offers traditional Chinese medicine derivatives products comprising Ahan antibacterial paste that is used to treat refractory chronic skin diseases; heparin products, including heparin sodium preparation, an ingredient for pharmaceutical companies to produce medications used in treating cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings, such as Zhu Xiaochang sausage casings for culinary purposes. Further, the company provides Fertilizer products comprising Xiongguan organic fertilizers to improve crop yield, increase soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers for plant growth. Additionally, it focuses on the AI-driven commercialization of DuXiaoBao platform to provide comprehensive and professional AI solutions and intelligent robot services for insurance companies, insurance brokers, and consumers. BGM Group Ltd. is based in Chengdu, China.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.